Xiaojuan Su

Department Of Pediatrics/Key Laboratory Of Birth Defects And Related Diseases Of Women And Children /NHC Key Laboratory Of Chronobiology
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Effects of TA-65 on telomere length, functional outcomes, and inflammation: a systematic review and meta-analysis.

Effects of TA-65 on telomere length, functional outcomes, and inflammation: a systematic review and meta-analysis.

Journal: Cell biology and toxicology

Published: July 29, 2025

The Gut Resistome Atlas in Preterm Infants Enables Prediction of Necrotizing Enterocolitis Onset.

The Gut Resistome Atlas in Preterm Infants Enables Prediction of Necrotizing Enterocolitis Onset.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 21, 2025

METTL3-mediated m⁶A methylation in cardiac diseases: pathogenic roles and therapeutic potential.

METTL3-mediated m⁶A methylation in cardiac diseases: pathogenic roles and therapeutic potential.

Journal: Cell biology and toxicology

Published: January 21, 2025

Methyltransferase-like 3 is a target for the diagnose and therapy of clear cell renal carcinoma.

Methyltransferase-like 3 is a target for the diagnose and therapy of clear cell renal carcinoma.

Journal: Frontiers in pharmacology

Published: November 26, 2024

Methyltransferase-like 3-mediated RNA N6-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target.

Methyltransferase-like 3-mediated RNA N6-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target.

Journal: Frontiers in immunology

Published: November 07, 2024

Methyltransferase-Like 3-Mediated N6-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases.

Methyltransferase-Like 3-Mediated N6-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases.

Journal: Journal of cellular and molecular medicine

Published: September 09, 2024

Mechanistic insights into vascular biology via methyltransferase-like 3-driven N6-adenosine methylation of RNA.

Mechanistic insights into vascular biology via methyltransferase-like 3-driven N6-adenosine methylation of RNA.

Journal: Frontiers in cell and developmental biology

Published: August 18, 2024

Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application.

Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 07, 2024

The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function.

The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function.

Journal: Frontiers in immunology

Published: June 29, 2024

Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target.

Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target.

Journal: Breast cancer research : BCR

Published: May 07, 2024

Altered expression of transfer RNAs and their possible roles in brain white matter injury.

Altered expression of transfer RNAs and their possible roles in brain white matter injury.

Journal: Neuroreport

Published: April 10, 2024

Long Non-Coding RNA PVT1 Inhibits Apoptosis Through the miR-30d-5p/CaMKIIδ Axis in Hypoxic-Ischemic Brain Injury.

Long Non-Coding RNA PVT1 Inhibits Apoptosis Through the miR-30d-5p/CaMKIIδ Axis in Hypoxic-Ischemic Brain Injury.

Journal: Molecular neurobiology

Published: January 31, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026